Skip to content

Preclinical and clinical study of siddha drugs Raja elathy choornam(internal) and Nathaichoori ennai(external) in the treatment of shoulder pain (Kumbavatham) with and without varmam.

Preclinical and clinical study of siddha drugs Raja elathy choornam(internal) and Nathaichoori ennai(external) in the treatment of kumbavatham (Peri arthritis shoulder) with and without varmam.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/05/008593
Enrollment
40
Registered
2017-05-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Kumbavatham (peri arthritis shoulder)

Interventions

Intervention1: Raja elathy choornam(internal) Nathaichoori ennai (external): 1 gm of Raja elathy choornam orally twice a day with hot water for a period of 48 days and Nathai choori ennai external app

Sponsors

Ayothidoss pandithar hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Pain and stiffness of shoulder region 2) Exacerbation of pain on movement 3) Restricted movements of shoulder joint 4) With or without pain radiating to upper arm 5) Patient willing to undergo radiological investigation and give blood samples for laboratory investigations 6) Patient willing to sign the informed consent stating that he/she will conciously stict to the treatment but can opt out of the trial of his/her own concious discretion

Exclusion criteria

Exclusion criteria: H/O Diabetes mellitus H/O Cardiac disease H/O septic arthritis H/O Gonococcal arthritis H/O Pregnancy and lactation H/O Malignant hypertention H/O Any fracture and dislocation of shoulder joint H/O Cervical spondylosis H/O Any other chronic illness

Design outcomes

Primary

MeasureTime frame
The outcome is aimed at reducing pain and stiffness in the shoulder joint Increasing the range of movements of shoulder joint measured by SPADITimepoint: 48 days

Secondary

MeasureTime frame
Effect of varmam in kumbavatham patients in addition to internal drugs evaluated by SPADI score To study siddha pricipals like envagai thervu, Neerkuri, Neikuri Safety assessment of the trial drugs by doing toxicology studies in animal models.Timepoint: 48 days

Countries

India

Contacts

Public ContactDrNJMuthukumar

National institute of siddha

njmuthu@hotmail.com9444206843

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026